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Abstract 
Arterial hypertension in patients with diabetes plays a main role in the earlier 
development of diabetic kidney disease (DKD), and endothelial dysfunction is considered 
to be a process involved in the development of diabetic complications. It is important to 
study the markers which gives the opportunity to identify DKD in early stage. In this 
article is presented a study of 24-hour Ambulatory Blood Pressure Monitoring 
(24hABPM) data in patients with diabetes and its interconnection with estimated 
glomerular filtration rate and endothelial dysfunction. The endothelial function was 
determined using the levels of TGF-b1(transforming growth factor-beta1) and VCAM-1 
(vascular cell adhesion molecule-1). In our study, we obtained convincing results that 
complex including endothelial dysfunction and results of 24hABPM can be considered as 
early signs of DKD progression in patients with diabetes. 
key words: diabetic kidney disease, endothelial dysfunction, 24hABPM, estimated 
glomerular filtration rate. 
Background and aims 
Diabetes mellitus (DM) is considered to be a 
disease accompanied by oxidative stress, chronic 
nonspecific inflammation, damage of the vessel 
wall, endothelial dysfunction (ED). DM is most 
often combined with arterial hypertension (AH). 
Insulin resistance (IR) is a common pathway for 
both – DM and AH. Endothelial dysfunction is 
the link between IR and cardiovascular disease 
[1]. AH in diabetic patients plays a main role in 
the earlier formation of diabetic kidney disease 
(DKD) - as an integral component of the 
cardiorenal continuum [2].  
Albuminuria (AU) is the "gold standard" for 
screening of DKD. But, the structural and 
functional changes in kidneys are developing 
long before we can see AU. It is known, that 20-
25% of nephrons are sclerosis at the stage of AU 
and from 50 to 70 % of nephrons - at the stage of 
proteinuria [3]. These changes point to 
irreversible kidney damage. It means the 
progressive reduction of kidney filtration and no 
therapy effect. Thus, the preclinical screening of 
DKD is highly important. It will give the 
opportunity to prescribe therapy earlier and 
slowing the progression of DKD. Today, there 
are many studies looking for markers of ED 
which allow to determine DKD in the early 
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stages, until changes in the kidneys are 
reversible. 
TGF-ß1 (transforming growth factor-beta1) 
is considered to be one of the main renal damage 
mediator. Studies have shown that TGF-β1 is an 
important mediator in development of chronic 
kidney disease (CKD). TGF-β1 helps the 
accumulation of extracellular matrix (ECM) in 
glomeruli (glomerular fibrosis, glomerulo-
sclerosis) and in tubular interstitial 
(tubulointerstitial fibrosis) [4,5]. Glomerulo-
sclerosis is the main cause of estimated 
glomerular filtration rate (eGFR) reducing. 
Three major types of glomerular cells (podocytes 
or visceral epithelial cells, mesangial and 
endothelial cells) are involved in the fibrotic 
process. The effect of TGF-ß1 caused by: 
apoptosis of podocytes (podocytopeniya), 
detachment by the basis of the glomerular 
membrane, hypertrophy of mesangial cells, 
epithelial-mesenchymal transformation (the 
formation of glomerular myofibroblast - the 
main source of ECM). 
VCAM-1 (vascular cell adhesion molecule-
1) is a mediator of the adhesion of circulating 
leukocytes (not related to neutrophils), 
monocytes, eosinophils, basophils to the 
endothelium. Also it is a mediator of 
transendotelial migration of these cells. ED is 
one of the first stages of atherogenesis, and 
VCAM-1 is considered as an early marker of 
atherosclerosis development [6]. It has proven 
that VCAM-1 is a reliable indicator of high risk 
of mortality from cardiovascular disease [7]. The 
elevated level of VCAM-1 is associated not only 
with coronary atherosclerosis but also with 
widespread atherosclerotic vascular damage. It 
has been shown, that elevated level of VCAM-1 
is a predictor of CKD in patients with type 1 
diabetes (T1DM) [8]. The development of CKD 
suggests the presence and progression of AH. 
Studies have shown that successful control of 
blood pressure prevents the rapid progression of 
vascular complications of diabetes and prolongs 
patient's life. 
Thus, it is necessary to study the changes in 
24-hour Ambulatory Blood Pressure Monitoring 
(24hABPM) in patients with DM. It is important 
to estimate the link between endothelial 
dysfunction and 24hABPM data as a predictor of 
DKD progression. 
The aim of this study is to evaluate the link 
study between 24hABPM data and concentration 
of endothelial function markers in patients with 
DM and different eGFR.  
Material and method 
The study included 124 patients with 
diabetes, 66 patients with T1DM, 58 with 
T2DM. Patients were involved into the study in 
the endocrinology department of the "Clinic of 
the Medical Academy", Dnipro, 2016-2017. 
Among the patients - 68 women and 56 men, age 
from 18 to 64 (33 ± 5.6) years. Duration of DM - 
3,5-25 (12 ± 6,3) years. The patients were 
divided into three groups depending on the 
eGFR: 1
st
 group - eGFR 90 ml / min / 1.73 m² 
and above; 2
nd
 group - eGFR 89-60 ml / min / 
1.73m²; 3
rd
 group - eGFR 59-45 ml / min / 
1.73m The control group consisted of 20 healthy 
persons. All patients were comparable for age 
and sex.  
Clinical and laboratory studies included: 
determination of serum creatinine level using the 
«SpinLab» (Ukraine), eGFR calculated by CKD-
EPI (Chronic Kidney Disease Epidemiology 
Collaboration). The endothelial function was 
determined by TGF-b1 and VCAM-1 using the 
«Bender Medsystems» (Austria) and «BCM 
Diagnostics» (Ukraine). Study was conducted in 
Diagnostic Center of «Pharmacy of Medical 
Academy», Dnipro. 24hABPM was carried out 
by a portable automatic monitor "VAT41-2" 
(Ukraine). Blood pressure measurements were 
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taken every 15 minutes during the day and every 
30 minutes during the night. The night interval 
was set between 10 PM to 7 AM. The following 
parameters, in 24hABPM readings, were taken 
into consideration to this study. Maximum of 
systolic blood pressure (max SBP), maximum of 
diastolic blood pressure (max DBP), total 
average systolic blood pressure (total average 
SBP); total average diastolic blood pressure 
(total average DBP), day systolic blood pressure 
> 140 mmHg in % (day SBP> 140 mmHg,%), 
day diastolic blood pressure > 90 mmHg in % 
(day DBP> 90 mmHg, % ), night systolic blood 
pressure>120 mmHg in % (night SBP>120 
mmHg, %), night diastolic blood pressure > 80 
mmHg in % (night DBP> 80 mmHg, %), dipper 
status (DS) (extreme dippers are defined by a 
reduction in BP by more than 20% from day to 
night, dippers - reduction in BP of 10-20 % from 
day to night , non-dippers  - reduction in BP by 
less than 10% from day to night, reverse dippers 
- decline in the nocturnal BP of <0 %. The day-
time BP less than or equal to 140/90 mmHg and 
the night-time BP less than or equal to 120/80 
mmHg were considered to be normal.  
The study was conducted according to the 
ethical principles of the Helsinki Declaration 
with the permission of the Bioethical 
Commission of the SE "Dnipropetrovsk Medical 
Academy of the Ministry of Health of Ukraine". 
Data were analyzed using Microsoft Excel, 
add-on program AtteStat and software 
STATISTICA 6.1 (StatSoftInc). The median 
(Me) and the interquartile range (25%, 75%) 
were used to describe the selective abnormal 
distribution of quantitative signs. To describe of 
the interconnections between different features 
was used a correlation analysis with the 
calculation of the Spearman rank correlation 
coefficients (ρ). Coefficient of correlation in the 
range 0.7 ≤ | ρ | <1 indicated a strong connection 
of correlation; 0.3 ≤ | ρ | <0.7 - for an average 
connection; 0 <| ρ | <0.3 - for a weak connection 
[10]. 
Results 
Patients of all study groups had significantly 
higher (p˂0.05) levels of TGF-b1 and VCAM-1 
(Table 1) in comparison with the control group. 
It’s demonstrate that patients with DM have 
endothelial dysfunction. 
In all study groups, in T2DM levels of TGF-
b1 and VCAM-1 were higher average by 1.3 and 
1.21 times, respectively. It happens because of 
longer duration of T2DM, less strong control of 
DM and presents of arterial hypertension and 
microangiopathy in all patients. Levels of TGF-
b1 and VCAM-1were increased with decreasing 
of eGFR regardless of type of diabetes. Thus, in 
T1DM level of TGF-b1 was higher for 57.0% 
and 78.7% in 2
nd
 and 3
rd
 group, respectively, 
than in 1
st
 group. In T2DM level of TGF-b1 was 
higher for 30% and 64.2% in 2
nd
 and 3
rd
 group, 
respectively, than in 1
st
 group. In T1DM level of 
VCAM-1 was higher for 16.2% and 46.2% in 2
nd
 
and 3
rd
 group, respectively, than in 1
st
 group. In 
T2DM level of VCAM-1 was higher for 18.3% 
and 47.4% in 2
nd
 and 3
rd
 group, respectively, 
than in 1
st
 group.  
It was shown that differences between levels 
of TGF-b1 (p1-2 = 0.001; p1-3 <0.001) and 
VCAM-1 (p1-2 = 0.001; p1-3 <0.001) in the 
study groups were the statistically significant. It 
was determined that levels of TGF-b1 and 
VCAM-1 have by reverse strong correlation with 
eGFR (ρ = -0.56, p <0.001) and (ρ = -0.51, p 
<0.001) respectively. The less eGFR, the higher 
rates of TGF-b1 and VCAM-1, which indicates 
the progression of endothelial dysfunction.  
The results of 24hABPM of patients of study 
groups are presented in Table 2. 
In the 1
st
 group it was determine the 
following features of 24hABPM (Table 2). 
There were no patients with hypertension in the 
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T1DM. But, according to the deeper status, it 
was determined that 28.0% of patients were 
"extreme-deeper"; 9.5% - "non-deeper", 62.5% - 
"deeper". There were 38.8% of patients with 
hypertension in the T2DM. According to the 
deeper status it was determined that 33.0% of 
patients were "non-deeper"; 16.0% - "reverse- 
deeper", 51.0% - "deeper". The significant 
differences between T1DM and T2DM of 1
st
 
group were determined by the: max. SBP (p 
<0.001); max DBP (p <0.001); day SBP> 140 
mmHg (p <0.001). These results show that 
T2DM patients with normal or elevated eGFR 
have AH and more expressed changes in 
circadian rhythm. This can be explained by a 
combination of insulin resistance, 
hyperinsulinemia and atherosclerotic vascular 
damage in patient with T2DM. All these factors 
potentiate each other's and lead to more earlier 
appearance of hypertension versus T1DM. 
Table 1. Differences in TGF-b1 and VCAM-1 in patients of study groups and control 
Indicators 
Me (25 %;75 %) 
T1DM T2DM p 
Control group p 
1
st
 Group (eGFR ≥ 90 ml / min / 1.73 m² ) 
TGF-b1, ng/ml 
16332,34 
(13422,76; 
18015,52) 
28934,6 (17118,26; 
39332,34) 
0,003 
9526,572 
(5726,05;  
11557,6) 
p1-2= 0,001; p1-
3< 0,001 
VCAM-1, pg/ml  
674,54 (539,97; 
764,75) 
811,75 (740,45; 
901,92) 
0,004 
551,2272 
(493,914 
717,593) 
p1-2= 0,001; p1-
3< 0,001 
2
nd
 Group (eGFR 89-60 90 ml / min / 1.73 m²) 
 
TGF-b1, ng/ml  37998,89 
(29927,94; 
39147,93) 
41633,59 (39664,41; 
48309,88) 
<0,001 9526,572 
(5726,05;  
11557,6) 
p1-2= 0,001; 
p1-3< 0,001 
VCAM-1, pg/ml 805,04 (698,73; 
982,51) 
993,6223 
 (796,69; 1213,26) 
<0,001 551,2272 
(493,914 
717,593) 
p1-2= 0,001;  
p1-3< 0,001 
3
rd
 Group (eGFR 59-45 ml / min / 1.73 m²)  
TGF-b1, ng/ml  
 
76838,11 
 (61207,08; 
82426,8) 
80840,4 (71987,8; 
87414,63) 
<0,001 
9526,572 
(5726,05;  
11557,6) 
p1-2= 0,001;  
p1-3< 0,001 
VCAM-1, pg/ml  
1255,708 
(966,53; 1520,31) 
1544,27 (1201,13; 
1865,97) 
<0,001 
551,2272 
(493,914 
717,593) 
p1-2= 0,001;  
p1-3< 0,001 
Note: p – is the difference between subgroups of different types of DM according to Mann-Whitney criterion; 
p 1-2 - is the difference between a subgroup of T1DM and a control group; 
p1-3 – - is the difference between a subgroup of T2DM and a control group. 
 
The multivariate logistic correlations were 
determined with the level of TGF-b1, VCAM-1 
and 24hABPM data. In 1
st
 group level of TGF -
b1 has reverse average correlation with deeper 
status (ρ = -0,32; p = 0.047); direct average 
correlation with total average SBP (ρ = 0,4; p = 
0,013), max SBP (ρ = 0,48; p = 0,002), max 
DBP (ρ = 0,32; p = 0,045), day SBP > 140 
mmHg (ρ = 0,5; p = 0,001); (ρ = 0,39; p = 
0,013), night SBP > 120 mmHg (ρ = 0,38; p = 
0,018), night DBP > 80 mmHg (ρ = 0.36; p = 
0.023). Correlation analysis demonstrate the 
differences in the level of TGF-b1 between 
T1DM and T2DM (ρ = 0.48; p = 0.002).  
It was shown that level of VCAM-1 has 
reverse average correlation with deeper status 
(ρ=-0,48; р=0,002), direct average correlation 
with total average SBP (ρ=0,39; р=0,015), max 
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SBP (ρ=0,45; р=0,004), max DBP (ρ=0,44; 
р=0,005), day SBP > 140 mmHg (ρ=0,46; 
р=0,004), night SBP > 120 mmHg (ρ=0,4; 
р=0,011). 
Table 2. Results of 24hABPM of study groups depending on estimated glomerular filtration rate (eGFR) 
Indicators 
Me 
(25 %;75 %) 
1
st
 Group  
(eGFR ≥ 90 ml / min / 
1.73 m² ) 
2
nd
 Group  
(eGFR 89-60 90 ml / min / 
1.73 m²) 
3
rd
 Group 
(eGFR 59-45 ml / min / 1.73 
m²) 
Comparasion 
between 
groups  
T1DM  T2DM  p T1DM  T2DM  p T1DM  T2DM  p 
Total 
average 
SBP  
124 
(122; 
130) 
134 
(124; 
144) 
0,005 
126 
(122; 
136) 
137,5 
(128; 
147) 
0,001 
143 
(137; 
147) 
146 
(140; 
154) 
0,15 
p1-2>0,05;  
p1-3<0,001; 
p2-3<0,001 
Total 
average 
DBP  
78 
(75; 
84) 
80,5 
(72; 
86) 
0,693 
82 
(78; 86) 
87,5 
(83; 93) 
0,003 
89,5 (86; 
95) 
92,5 (88; 
97) 
0,192 
p1-2=0,015;  
p1-3<0,001;  
p2-3=0,001 
Max SBP  
135 
(133; 
141) 
159,5 
(151; 
168) 
<0,001 
142 
(137; 
146) 
162 
(154; 
169) 
<0,001 
165,5 
(157; 
182) 
171 
(158; 
183) 
0,634 
p1-2>0,05;     
p1-3<0,001;    
p2-3<0,001 
Max DBP  
90 
(87; 
92) 
96 
(94; 
99) 
<0,001 
92 
(88; 96) 
101 
(97; 
104) 
<0,001 
102 (98; 
111) 
102 (98; 
112) 
0,86 
p1-2>0,05;     
p1-3<0,001;     
p2-3<0,001 
Day SBP> 
140 
mmHg,%  
0 (0; 
4) 
14,55 
(2,7; 
22,69) 
<0,001 
5 (0; 
12,4) 
33,7 
(13,48; 
52,7) 
<0,001 
33,45 
(24; 
38,4) 
36,9 
(33,2; 
54) 
0,112 
p1-2=0,009;    
p1-3<0,001;     
p2-3<0,001 
Day DBP> 
90 
mmHg,%  
1,2 (0; 
5) 
4,93 
(2,3; 
16) 
0,022 
0 (0; 
4,9) 
24,25 
(6,4; 
39,1) 
<0,001 
27,75 
(19,4; 
36,4) 
36,8 
(27,6; 
47,4) 
0,084 
p1-2>0,05;     
p1-3<0,001;    
p2-3<0,001 
Night 
SBP>120 
mmHg, % 
0 (0; 
2) 
2,86 
(0; 27) 
0,099 
3,8 
(0; 
15,4) 
51,4 
(34,2; 
87) 
<0,001 
31,36 
(22,5; 
42) 
33,85 
(27,1; 
54,2) 
0,289 
p1-2<0,001;     
p1-3<0,001;    
p2-3>0,05 
Night 
DBP>80 
mmHg, % 
0 (0; 
1,51) 
3,13 
(0; 18) 
0,032 
1,8 
(0; 
19,3) 
38,5 
(9,64; 
60,32) 
<0,001 
31,05 
(23,8; 
48) 
38,05 
(25,4; 
49,1) 
0,308 
p1-2=0,001;    
p1-3<0,001;     
p2-3=0,004 
Note. p - differences between T1DM and T2DM subgroups according to the Mann-Whitney criterion; comparison using 
the nonparametric dispersion analysis of Kruskal-Wallis 
 
In the 2
nd
 group there were established the 
following features of the 24hABPM. In the 
T1DM 26% of patients had hypertension. 8,6% 
patient of this patients were "extreme-deeper", 
34,7% - «non-deeper», 52,0% - «deeper», 4,7% - 
«reverse- deeper». There were demonstrated the 
significant differences (p <0,001) between 
T1DM and T2DM of 2
nd
 group by the: total 
average SBP, total average ВBP, max SBP, max 
DBP, day SBP > 140 mmHg, day DBP > 90 
mmHg, night SBP > 120 mmHg, night DBP > 
80 mmHg. These rates were higher in patients 
with T2DM. 
In 2
nd
 group we also estimated that level of 
TGF -b1 has: reverse correlation with deeper 
status (ρ=-0,44; р=0,003), direct average 
correlation with max SBP (ρ=0,38; р=0,010), 
max DBP(ρ=0,4; р=0,007), day SBP > 140 
mmHg (ρ=0,34; р=0,022), day DBP > 90 mmHg 
(ρ=0,34; р=0,024), night SBP > 120 mmHg 
(ρ=0,47; р=0,001). As a result, we have an 
evidence of the differences in the level of TGF-
b1 between T1DM and T2DM (ρ=0,59; 
р<0,001). 
It was determined that level of VCAM-1 has 
reverse average correlation with DS (ρ=-0,48; 
р=0,002), direct average correlation with total 
average SBP (ρ=0,39; р=0,015), max SBP 
(ρ=0,45; р=0,004), max DBP (ρ=0,44; 
р=0,005), day SBP > 140 mmHg (ρ=0,46; 
р=0,004), night SBP > 120 mmHg (ρ=0,4; 
р=0,011). 
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In the 3
rd
 group there were showed the 
following features of the 24hABPM. In the 
T1DM 63,6% of patients had hypertension. 59% 
patient of this patients were «non-deeper», 22,7 
% - «reverse- deeper», 18,3% - «deeper». In the 
T2DM 94,44% of patients had hypertension. 
66,6% patient of this subgroup were «non-
deeper», 33,3% - «reverse- deeper», 0,01% - 
«deeper». There were no evident differences of 
24hABPM indicators between T1DM and 
T2DM patients. Results of 24hABPM 
significantly worsened with the decreased of 
eGFR. In T1DM, in 3
rd
 group, the number of 
patients with AH was 63.6%, while in 1
st
 group 
there no patients with hypertension. In 3
rd
 group, 
the number of "non-deeper" was more for 
83.8%, and the number of "deeper" was less for 
70% than in 1
st
 group. The activation of renin-
angiotensin-aldosterone system (RAAS) leads to 
increased reviling of AH and changes in 
circadian rhythm in patients with T1DM. All this 
conducted to DKD progression.  
The multivariate logistic correlation was 
determined with TGF -b1, VCAM-1 and 
24hABPM data in the 3
rd
 group. The level of 
TGF -b1 has: reverse average correlation with 
deeper status (ρ=-0,43; р=0,006), direct average 
correlation with total average SBP (ρ=0,47; 
р=0,002) and total average DBP (ρ=0,51; 
р=0,001). 
It was evaluated that level of VCAM-1 has 
reverse average correlation with DS (ρ=-0,48; 
р=0,002), direct average correlation with max 
SBP (ρ=0,36; р=0,024), night SBP > 120 mmHg 
(ρ=0,37; р=0,020), night DBP>80 mmHg 
(ρ=0,32; р=0,045). 
Discussion 
Most authors consider changes of circadian 
rhythm of BP as a marker of target organs being 
damaged [11]. In our study, it was shown that 
the results of 24hABPM of patients with DM 
were expressed in progression changes of 
circadian rhythm according to the decline of 
eGFR. The results of the study have 
demonstrated that the more decline of eGFR, the 
more number of patients having insufficient 
decrease of nocturnal BP. This process didn’t 
depend on the type of diabetes but was more 
obvious in patients with T2DM (T1DM - 43.8% 
vs T2DM - 74.1%). 
Today most researchers consider the factors 
of endothelial function as possible early markers 
of DKD progression [12-14]. Important, that we 
determined the elevated levels of TGF-b1 and 
VCAM-1 in patients with DM without clinical 
signs of DKD. And there were significant 
differences between patients with DM and 
healthy (p < 0,005). In addition to, it was found 
the significant differences of levels of TGF-b1 
and VCAM-1 between study groups (p1-2= 
0,001; p1-3< 0,001). Thus, we have shown that 
the increase TGF-b1 and VCAM-1 concentration 
were an independent factor of ED aggravation 
the likelihood of DKD. 
Conclusion 
The results of the study show that significant 
(p <0.005) changes of circadian rhythm in 
patients with diabetes in the early stages of DKD 
(stage of hyperperfusion and normal or elevated 
eGFR) determined by 24hABPM. In patients 
with T1DM and T2DM it was shown an increase 
number of «non-dipper» from 7.5% to 27.5% 
and «reverse-dipper» from 20% to 60.5% 
depending on the eGFR decline: in group of 
patients with eGFR ≥90 ml / min / 1, 73m³ and 
with GFR 59-45 ml / min / 1.73m³, respectively. 
Lowering of blood pressure at night in patients 
with T1DM and T2DM was insufficient: deeper 
status (p = 0.018). That confirm the progression 
of DKD in these patients. In the study, we 
obtained convincing results that the levels of 
markers of endothelial function - TGF-b1 and 
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VCAM-1 in patients with T1DM and T2DM 
were quantitatively dependent on eGFR. The 
levels of TGF-b1 and VCAM-1 in patient with 
DM and DKD (stage of hyperperfusion and 
elevated levels of eGFR) significantly differed (p 
<0.005) from the control. The strong and 
average correlations were detected between 
levels of TGF-b1, VCAM-1 and results of 
24hABPM. We can conclude that complex 
including results of 24hABPM and endothelial 
dysfunction can be considered as early signs of 
DKD progression. 
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